There's enough money in 'crank health' that, if it were possible to publish something that might have a chance of lending some credibility (and thus expanding the breadth of the vulnerable customer base), then I would think it would have been done already.
This implies to me that the counter-evidence is strong and complete enough to discourage 'investment' into such a pursuit.
>There's enough money in 'crank health' that,
But there is many order of magnitude more money invested in preventing the publication of something like that..
All the "reputed" journals who gets funded by pharma would not touch such a study, despite any merits it have. This is so apparent to anyone who is not completely oblivious of how the world work that no one in their right mind will even attempt to fund such a study...